<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Crank_The_LY2109761_Into_A_Complete_Goldmine</id>
		<title>Crank The LY2109761 Into A Complete Goldmine - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Crank_The_LY2109761_Into_A_Complete_Goldmine"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Crank_The_LY2109761_Into_A_Complete_Goldmine&amp;action=history"/>
		<updated>2026-04-28T07:24:24Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Crank_The_LY2109761_Into_A_Complete_Goldmine&amp;diff=176243&amp;oldid=prev</id>
		<title>Net64tax: Створена сторінка: All data are expressed as means �� SEM. Student's t-test was used for parametric comparisons. Because the data did not meet the requirements for parametric...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Crank_The_LY2109761_Into_A_Complete_Goldmine&amp;diff=176243&amp;oldid=prev"/>
				<updated>2017-05-14T04:22:36Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: All data are expressed as means �� SEM. Student&amp;#039;s t-test was used for parametric comparisons. Because the data did not meet the requirements for parametric...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;All data are expressed as means �� SEM. Student's t-test was used for parametric comparisons. Because the data did not meet the requirements for parametric analysis, the numbers of VEGF-C+ mononuclear cells in normal DA tracheas, syngrafts, and allografts in nonimmunosuppressed recipients 10 and 30 days after transplantation were compared using the Mann-Whitney test. Epithelial expression of VEGFR-3 in the same samples was analyzed using Mann-Whitney test, because of the nonparametric scoring method. Linear regression analysis was applied to evaluate a possible relation of increasing CsA doses to lymphangiogenesis and development of luminal occlusion. All analyses were performed using Abacus Concepts StatView version 4.1 software (SAS Institute, Cary, NC). P  as statistically significant. Lymphangiogenesis is generally induced [http://www.selleckchem.com/products/ly2109761.html LY2109761 mw] during chronic inflammation.13?and?14 We investigated whether it also occurs during the development of OAD in rat tracheal allografts. We first analyzed lymphangiogenesis and the kinetics of VEGF-C and VEGFR-3 expression during the development of OAD in nonimmunosuppressed normal DA tracheas, syngrafts (DA��DA), and allografts (DA��WF, fully MHC-mismatched) by immunohistochemistry at 10 and 30 days. Comparison of normal tracheas versus syngrafts permitted us to distinguish between [http://en.wikipedia.org/wiki/MAPK MAPK] changes in lymphatic vessel density and in VEGF-C and VEGFR-3 expression induced by the transplantation procedure or by transplantation-linked ischemia and innate immune response; comparison of syngrafts versus allografts allowed us to detect changes caused by the alloimmune response without interference of immunosuppression. In brief, in nonimmunosuppressed syngrafts, the epithelium showed ischemic injury at 3 days (data not shown) but recovered 10 days after transplantation (Figure 1, A and C), and no myofibroproliferation was observed at either time point (Figure 1, E and G). In nonimmunosuppressed allografts, progressive loss of epithelium was seen at 10 days (Figure [http://www.selleckchem.com/products/epz-5676.html selleck kinase inhibitor] 1, A and D), and intense myofibroproliferation totally occluding the airway lumen was seen at 30 days (Figure 1, E and H). Immunohistochemical staining for ��-SMC actin confirmed the fibroproliferative character of the occlusion area (Figure 1H, inset). We used lymphatic endothelium-specific hyaluronan receptor (LYVE-1) antibody as a marker for lymphatic vessels.21 Compared with syngrafts, immunohistochemical staining showed a more than threefold number of LYVE-1+ lymphatic vessels in allografts at 10 days (P&lt;/div&gt;</summary>
		<author><name>Net64tax</name></author>	</entry>

	</feed>